Skip to main content
. 2022 Oct 3;10:1001558. doi: 10.3389/fcell.2022.1001558

TABLE 1.

Clinical Characteristics of COVID-19 Patients at recovery stage (R1-R9) and Healthy controls (H1-H5) in this study.

No Gender Ethnicity Age (yrs) Disease severity Disease duration (days) Time from discharge to sampling (days) BMI CoV-IgM CoV-IgG
R1 Male Chinese 31 Mild1 26 70 25.95 + +
R2 Male Chinese 29 Mild2 25 79 20.05 + +
R3 Male Chinese 24 Moderate1 17 76 28.07 - +
R4 Male Chinese 36 Moderate2 13 83 26.23 - +
R5 Male Chinese 43 Mild3 12 89 23.66 - +
R6 Male Chinese 40 Mild4 32 96 35.43 - +
R7 Male Chinese 39 Moderate3 9 98 32.1 - +
R8 Male Chinese 36 Moderate4 24 78 26.78 - +
R9 Male Chinese 43 Mild5 21 107 25.33 - +
H1 Male Chinese 28 Healthy N/A N/A 26.4 - -
H2 Male Chinese 28 Healthy N/A N/A 21.3 - -
H3 Male Chinese 32 Healthy N/A N/A 21.3 - -
H4 Male Chinese 39 Healthy N/A N/A 23.0 - -
H5 Male Chinese 37 Healthy N/A N/A 22.9 - -

Comparison between COVID-19 group and control group showed no significant differences of age (p > 0.05) or BMI (p > 0.05). Note that average time from discharge to sampling of COVID-19 patients (R1–R9) was 86 days (about 3 months), and median age was 36 years.